Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

Nov 15, 2013

30198_dirs_2013-11-15_7bd9ff67-0f9c-4b72-8c07-36ddae138fe6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-11-13

Reporting Person: LISTER JOHN (General Counsel, VP of HR)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-13 Common Stock S 2700.0 $33.5115 Disposed 71326 Direct
2013-11-13 Common Stock M 7300.0 $4.58 Acquired 78626 Direct
2013-11-13 Common Stock S 7300.0 $33.4068 Disposed 71326 Direct
2013-11-13 Common Stock M 9372.0 $3.19 Acquired 80698 Direct
2013-11-13 Common Stock S 9372.0 $33.5498 Disposed 71326 Direct
2013-11-13 Common Stock M 3128.0 $3.19 Acquired 74454 Direct
2013-11-13 Common Stock S 3128.0 $33.4801 Disposed 71326 Direct
2013-11-13 Common Stock M 6718.0 $7.63 Acquired 78044 Direct
2013-11-13 Common Stock S 6718.0 $33.4068 Disposed 71326 Direct
2013-11-13 Common Stock M 782.0 $7.63 Acquired 72108 Direct
2013-11-13 Common Stock S 782.0 $33.4068 Disposed 71326 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-13 Incentive Stock Option (right to buy) $3.19 M 3128.0 Disposed 2018-12-11 Common Stock (3128) Direct
2013-11-13 Incentive Stock Option (right to buy) $7.63 M 782.0 Disposed 2018-05-19 Common Stock (782) Direct
2013-11-13 Non-Qualified Stock Option (right to buy) $4.58 M 7300.0 Disposed 2019-05-19 Common Stock (7300) Direct
2013-11-13 Non-Qualified Stock Option (right to buy) $7.63 M 6718.0 Disposed 2018-05-19 Common Stock (6718) Direct
2013-11-13 Non-Qualified Stock Option (right to buy) $3.19 M 9372.0 Disposed 2018-12-11 Common Stock. (9372) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $33.511 to $33.512. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 55,855 unvested restricted stock units, 35,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 16,563 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 4,292 of which were granted on March 8, 2011 and shall vest through March 8, 2014.